New Developments in Autism

Psychiatric Clinics of North America

Volumn 32, Issue 1, 2009, Pages 1-14

  Bertoglio, Kiah ^a   Hendren, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Diagnosis; Epidemiology; Etiology; Psychopharmacology; Treatment

Indexed keywords

AMPHETAMINE; ARIPIPRAZOLE; ATOMOXETINE; CLONIDINE; FLUOXETINE; GUANFACINE; METHYLPHENIDATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM;

AGGRESSION; AKATHISIA; AUTISM; BEHAVIOR THERAPY; CLINICAL FEATURE; DECREASED APPETITE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET THERAPY; ENVIRONMENTAL FACTOR; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GENETIC SUSCEPTIBILITY; HUMAN; HYPOTENSION; INSOMNIA; IRRITABILITY; NAUSEA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SEDATION; SIDE EFFECT; STEREOTYPY; WEIGHT GAIN;

AUTISTIC DISORDER; CHILD, PRESCHOOL; HUMANS;

EID: 60549088280     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2008.10.004     Document Type: Review

References (91)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (2000), American Psychiatric Association, Arlington (VA) p. 84
2. Lord C., and Spence S. Autism spectrum disorders: phenotype and diagnosis. In: Moldin S.O., and Rubenstein J.L.R. (Eds). Understanding autism: from basic neuroscience to treatment (2006), CRC Press, Boca Raton (FL) 1-24
3. In: Lord C., and McGee J. (Eds). Educating children with autism (2001), National Academy Press, Washington, DC
4. Ganz M.L. The costs of autism. In: Moldin S.O., and Rubenstein J.L.R. (Eds). Understanding autism: from basic neuroscience to treatment (2006), CRC Press, Boca Raton (FL) 475-502
5. Bertrand J., Mars A., Boyle C., et al. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatrics 108 5 (2001) 1155-1161
6. Steinhausen H.C., Gobel D., Breinlinger M., et al. A community survey of infantile autism. J Am Acad Child Psychiatry 25 2 (1986) 186-189
7. Taylor B. Vaccines and the changing epidemiology of autism. Child Care Health Dev 32 5 (2006) 511-519
8. Yeargin-Allsopp M., Rice C., Karapurkar T., et al. Prevalence of autism in a US metropolitan area. JAMA 289 1 (2003) 49-55
9. Fombonne E., Simmons H., Ford T., et al. Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. J Am Acad Child Adolesc Psychiatry 40 7 (2001) 820-827
10. Dyches T.T., Wilder L.K., Sudweeks R.R., et al. Multicultural issues in autism. J Autism Dev Disord 34 2 (2004) 211-222
11. Liptak G.S., Benzoni L.B., Mruzek D.W., et al. Disparities in diagnosis and access to health services for children with autism: data from the National Survey of Children's Health. J Dev Behav Pediatr 29 3 (2008) 152-160
12. What is autism? Advocate: the newsletter of the Autism Society of America. 2000; 33(3).
13. Pediatrics AAo. The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children. Pediatrics 107 (2001) 1221-1226
14. Mundy P. Annotation: the neural basis of social impairments in autism: the role of the dorsal medial-frontal cortex and anterior cingulate system. J Child Psychol Psychiatry 44 6 (2003) 793-809
15. Rogers S.J., Hepburn S.L., Stackhouse T., et al. Imitation performance in toddlers with autism and those with other developmental disorders. J Child Psychol Psychiatry 44 5 (2003) 763-781
16. Tuchman R. Autism. Neurol Clin 21 4 (2003) 915-932 viii
17. Rogers S.J. Developmental regression in autism spectrum disorders. Ment Retard Dev Disabil Res Rev 10 2 (2004) 139-143
18. Karande S. Autism: a review for family physicians. Indian J Med Sci 60 5 (2006) 205-215
19. Eisenmajer R., Prior M., Leekam S., et al. Comparison of clinical symptoms in autism and Asperger's disorder. J Am Acad Child Adolesc Psychiatry 35 11 (1996) 1523-1531
20. Miller J.N., and Ozonoff S. The external validity of Asperger disorder: lack of evidence from the domain of neuropsychology. J Abnorm Psychol 109 2 (2000) 227-238
21. Klin A., and Volkmar F.R. Asperger syndrome: diagnosis and external validity. Child Adolesc Psychiatr Clin N Am 12 1 (2003) 1-13 v
22. Szatmari P., Bremner R., and Nagy J. Asperger's syndrome: a review of clinical features. Can J Psychiatry 34 6 (1989) 554-560
23. Fine J., Bartolucci G., Szatmari P., et al. Cohesive discourse in pervasive developmental disorders. J Autism Dev Disord 24 3 (1994) 315-329
24. Macintosh K.E., and Dissanayake C. Annotation: the similarities and differences between autistic disorder and Asperger's disorder: a review of the empirical evidence. J Child Psychol Psychiatry 45 3 (2004) 421-434
25. Lord C., Rutter M., Goode S., et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 19 2 (1989) 185-212
26. Lord C., Rutter M., and Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24 5 (1994) 659-685
27. Baird G., Charman T., Baron-Cohen S., et al. A screening instrument for autism at 18 months of age: a 6-year follow-up study. J Am Acad Child Adolesc Psychiatry 39 6 (2000) 694-702
28. Palomo R., Belinchon M., and Ozonoff S. Autism and family home movies: a comprehensive review. J Dev Behav Pediatr 27 2 Suppl (2006) S59-S68
29. Filipek P.A., Accardo P.J., Ashwal S., et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 55 4 (2000) 468-479
30. Hansen R. Contributions of pediatrics. In: Ozonoff S., Rogers S.J., and Hendren R.L. (Eds). Autism spectrum disorders: a research review for practitioners (2003), American Psychiatric Publishing, Inc., Washington, DC 87-109
31. Keller F., and Persico A.M. The neurobiological context of autism. Mol Neurobiol 28 1 (2003) 1-22
32. Beaudet A.L. Is medical genetics neglecting epigenetics?. Genet Med 4 5 (2002) 399-402
33. London E.A. The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect 108 Suppl 3 (2000) 401-404
34. Freitag C.M., Kleser C., and von Gontard A. Imitation and language abilities in adolescents with Autism Spectrum Disorder without language delay. Eur Child Adolesc Psychiatry 15 5 (2006) 282-291
35. Reichenberg A., Gross R., Weiser M., et al. Advancing paternal age and autism. Arch Gen Psychiatry 63 9 (2006) 1026-1032
36. Philippe A., Martinez M., Guilloud-Bataille M., et al. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet 8 5 (1999) 805-812
37. Muhle R., Trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 113 5 (2004) e472-e486
38. Campbell D.B., Sutcliffe J.S., Ebert P.J., et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A 103 45 (2006) 16834-16839
39. Miyazaki K., Narita N., and Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int J Dev Neurosci 23 2-3 (2005) 287-297
40. Mutter J., Naumann J., Schneider R., et al. Mercury and autism: accelerating evidence?. Neuro Endocrinol Lett 26 5 (2005) 439-446
41. Young H.A., Geier D.A., and Geier M.R. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 271 1-2 (2008) 110-118
42. Ashwood P., Wills S., and Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol 80 1 (2006) 1-15
43. Tharp B.R. Epileptic encephalopathies and their relationship to developmental disorders: do spikes cause autism?. Ment Retard Dev Disabil Res Rev 10 2 (2004) 132-134
44. Chez M.G., Chang M., Krasne V., et al. Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav 8 1 (2006) 267-271
45. Aldred S., Moore K.M., Fitzgerald M., et al. Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 33 1 (2003) 93-97
46. Zoroglu S.S., Armutcu F., Ozen S., et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 254 3 (2004) 143-147
47. Sogut S., Zoroglu S.S., Ozyurt H., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331 1-2 (2003) 111-117
48. James S.J., Cutler P., Melnyk S., et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80 6 (2004) 1611-1617
49. Yorbik O., Sayal A., Akay C., et al. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 67 5 (2002) 341-343
50. Bauman M.L., and Kemper T.L. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci 23 2-3 (2005) 183-187
51. Courchesne E. Abnormal early brain development in autism. Mol Psychiatry 7 Suppl 2 (2002) S21-S23
52. Courchesne E., Karns C.M., Davis H.R., et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57 2 (2001) 245-254
53. Sparks B.F., Friedman S.D., Shaw D.W., et al. Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59 2 (2002) 184-192
54. Redcay E., and Courchesne E. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 58 1 (2005) 1-9
55. Herbert M.R. Large brains in autism: the challenge of pervasive abnormality. Neuroscientist 11 5 (2005) 417-440
56. Kern J.K. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 25 6 (2003) 377-382
57. Kielinen M., Rantala H., Timonen E., et al. Associated medical disorders and disabilities in children with autistic disorder: a population-based study. Autism 8 1 (2004) 49-60
58. Werner E., and Dawson G. Validation of the phenomenon of autistic regression using home videotapes. Arch Gen Psychiatry 62 8 (2005) 889-895
59. Mottron L., Dawson M., Soulieres I., et al. Enhanced perceptual functioning in autism: an update, and eight principles of autistic perception. J Autism Dev Disord 36 1 (2006) 27-43
60. Cohly H.H., and Panja A. Immunological findings in autism. Int Rev Neurobiol 71 (2005) 317-341
61. Ashwood P., and Van de Water J. A review of autism and the immune response. Clin Dev Immunol 11 2 (2004) 165-174
62. Erickson C.A., Stigler K.A., Corkins M.R., et al. Gastrointestinal factors in autistic disorder: a critical review. J Autism Dev Disord 35 6 (2005) 713-727
63. Munesue T., Ono Y., Mutoh K., et al. High prevalence of bipolar disorder comorbidity in adolescents and young adults with high-functioning autism spectrum disorder: a preliminary study of 44 outpatients. J Affect Disord 11 2 (2008) 170-175
64. Huttenlocher P.R. Synapse elimination and plasticity in developing human cerebral cortex. Am J Ment Defic 88 5 (1984) 488-496
65. Lovaas O.I. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol 55 1 (1987) 3-9
66. Seltzer M.M., Shattuck P., Abbeduto L., et al. Trajectory of development in adolescents and adults with autism. Ment Retard Dev Disabil Res Rev 10 4 (2004) 234-247
67. Rogers S.J., Hayden D., Hepburn S., et al. Teaching young nonverbal children with autism useful speech: a pilot study of the Denver Model and PROMPT interventions. J Autism Dev Disord 36 8 (2006) 1007-1024
68. Mesibov G.B. Commentary: facilitated communication: a warning for pediatric psychologists. J Pediatr Psychol 20 1 (1995) 127-130
69. Koegel P., Sullivan G., Burnam A., et al. Utilization of mental health and substance abuse services among homeless adults in Los Angeles. Med Care 37 3 (1999) 306-317
70. Findling R.L. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. J Clin Psychiatry 66 Suppl 10 (2005) 26-31
71. Barnard L., Young A.H., Pearson J., et al. A systematic review of the use of atypical antipsychotics in autism. J Psychopharmacol 16 1 (2002) 93-101
72. Hollander E., Phillips A., Chaplin W., et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 30 3 (2005) 582-589
73. Findling R.L., Steiner H., and Weller E.B. Use of antipsychotics in children and adolescents. J Clin Psychiatry 66 Suppl 7 (2005) 29-40
74. Scahill L., McCracken J., McDougle C.J., et al. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. J Child Adolesc Psychopharmacol 11 4 (2001) 377-388
75. Wolraich M.L., Wibbelsman C.J., Brown T.E., et al. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics 115 6 (2005) 1734-1746
76. Hazell P. Does the treatment of mental disorders in childhood lead to a healthier adulthood?. Curr Opin Psychiatry 20 4 (2007) 315-318
77. Hollander E., Dolgoff-Kaspar R., Cartwright C., et al. An open trial of divalproex sodium in autism spectrum disorders. J Clin Psychiatry 62 7 (2001) 530-534
78. Hollander E., Soorya L., Wasserman S., et al. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol 9 2 (2006) 209-213
79. Goin-Kochel R.P., Mackintosh V.H., and Myers B.J. How many doctors does it take to make an autism spectrum diagnosis?. Autism 10 5 (2006) 439-451
80. Green V.A., Pituch K.A., Itchon J., et al. Internet survey of treatments used by parents of children with autism. Res Dev Disabil 27 1 (2006) 70-84
81. Wong H.H., and Smith R.G. Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. J Autism Dev Disord 36 7 (2006) 901-909
82. Rossignol D.A., Rossignol L.W., James S.J., et al. The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study. BMC Pediatr 7 (2007) 36
83. Amminger G.P., Berger G.E., Schafer M.R., et al. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61 4 (2007) 551-553
84. Levy S.E., and Hyman S.L. Novel treatments for autistic spectrum disorders. Ment Retard Dev Disabil Res Rev 11 2 (2005) 131-142
85. Millward C., Ferriter M., Calver S., et al. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev 2 (2008) CD003498
86. White J.F. Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 228 6 (2003) 639-649
87. Boris M., Kaiser C.C., Goldblatt A., et al. Effect of pioglitazone treatment on behavioral symptoms in autistic children. J Neuroinflammation 4 (2007) 3
88. Chez M.G., Burton Q., Dowling T., et al. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol 22 5 (2007) 574-579
89. Filipek P.A., Steinberg-Epstein R., and Book T.M. Intervention for autistic spectrum disorders. NeuroRx 3 2 (2006) 207-216
90. Available at:. www.Autism-Society.org Accessed September 13, 2008
91. Available at:. www.AutismSpeaks.org Accessed September 13, 2008